GleamWall
中文EN

CFOO China Foods Holdings Ltd.

Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1310630 · Fiscal year ends 12/31

Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY-46.6%
TTM net income YoY33.6%
TTM EPS YoY0.0%
Revenue 3-yr CAGR-3.9%
Net income 3-yr CAGR—

Margins

Gross margin7.9%
Operating margin-173.9%
Net margin-173.8%
FCF margin—
EBITDA margin-170.1%

Returns

ROE—
ROA-114.1%
ROIC (approx.)—
Asset turnover0.66x

Leverage & solvency

Liabilities / assets756.1%
Debt / equity—
Current ratio0.11x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.09x
Accruals ratio10.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$327,871$233,339
Cost of revenue$297,909$179,466
Gross profit$29,962$53,873
SG&A expense$423,644$502,654
Operating income-$398,923-$455,637
Pretax income-$398,672-$454,735
Income tax—$836
Net income-$398,672-$455,571
EBITDA-$391,934-$453,869
EPS (basic)-0.02-0.02
EPS (diluted)-0.02-0.02
Weighted avg. shares (diluted)20.25M20.25M
Banking
Net interest income$45$329
Balance sheet
Cash & equivalents$9,893$39,192
Inventory$39,255$54,943
Current assets$162,943$398,686
PP&E, net$27,860$34,264
Intangibles$1,662$2,055
Total assets$212,890$435,005
Current liabilities$1.48M$1.29M
Total liabilities$1.49M$1.29M
Shareholders' equity-$1.28M-$850,807
Shares outstanding20.25M20.25M
Cash flow statement
Operating cash flow-$389,251-$353,812
Capital expenditure—$23,454
Free cash flow—-$377,266
Investing cash flow—-$23,454
Financing cash flow$388,605$245,524
Depreciation & amortization$6,989$1,768

Free plan shows the latest 2 periods; Pro shows all 23 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.